Systemic mutagen exposures reported by normal kidney cell genomes

By analyzing single-molecule duplex sequencing data from normal kidney and blood samples across 10 countries, researchers discovered that kidney proximal tubule cells accumulate high levels of somatic mutations from both known exogenous carcinogens, such as aristolochic acids, and unidentified systemic mutagens, revealing these cells as highly sensitive sentinels for detecting widespread environmental exposures.

The Gist

Imagine your body as a massive, bustling city. Every cell in that city is like a house, and inside each house is a blueprint called DNA. Over time, these blueprints get scribbled on, smudged, or torn up. These scribbles are called mutations.

Usually, we think of these scribbles as the start of a disaster (cancer). But this paper is like a team of forensic detectives who realized that these scribbles aren't just random noise. They are actually receipts.

Here is the story of what they found, explained simply:

1. The Detective Work: Reading the "Receipts"

The researchers looked at the kidneys of 319 people from 10 different countries. They used a super-powerful microscope (called NanoSeq) that can read DNA so precisely it can spot a single typo in a billion-letter book.

They didn't just look at cancer cells; they looked at healthy, normal kidney cells. Why? Because if a poison or a bad habit leaves a mark on your DNA, it leaves that mark first in your healthy cells, long before a tumor ever forms.

2. The Kidney: The Body's "Filter Plant"

Think of your kidney as a giant water filtration plant. It takes blood, filters out the waste, and sends clean blood back to the body.

• The Problem: As the water flows through the pipes (the kidney tubules), it picks up everything you've eaten, drunk, or breathed in.
• The Discovery: The detectives found that the Proximal Tubules (the main pipes where the heavy lifting happens) were covered in scribbles. In fact, these pipes had more mutations than almost any other healthy tissue in the human body, even though the cells there don't divide very often.

Analogy: Imagine a coffee filter. If you pour dirty water through it, the filter gets stained. The more dirty water you pour, the darker the stain gets. The kidney's "filter pipes" are getting stained by the toxins circulating in our blood.

3. The "Smudges" Tell a Story

The researchers didn't just count the scribbles; they looked at the shape of the scribbles. Different bad actors leave different types of marks. They found several specific "fingerprints":

• The Aristolochia Fingerprint (SBS22): In countries like Romania and Serbia, they found a very specific, heavy smudge pattern. This is caused by Aristolochic Acid, a poison found in certain plants (sometimes used in traditional herbal medicines). It's like finding a specific brand of ink that only comes from a certain factory. The fact that healthy kidney cells had this ink proved that people were ingesting this poison, and it was circulating through their whole bodies.
• The Japanese Mystery (SBS12): In Japan, they found a unique smudge pattern that no one else had. It's like finding a secret code that only exists in one city. This suggests there is a specific, unknown environmental toxin in Japan that is circulating in the blood and damaging kidneys.
• The Smoking Fingerprint (SBSB): They found marks in the kidneys of smokers that looked like the marks found in lung cancer. This proves that smoking doesn't just hurt your lungs; the chemicals travel through your blood and damage your kidneys, too.
• The "Unknown Suspects" (SBS40b & SBS40c): They found other smudges that appear in different countries in different amounts. One was very common in the Czech Republic but rare in Japan. This suggests there are other common, system-wide poisons in our environment that we haven't identified yet.

4. The Blood vs. The Kidney

The team also checked the blood of these people.

• The Surprise: The blood was surprisingly clean. It didn't show the heavy "smudges" of the kidney toxins.
• The Lesson: Blood is like the highway; the toxins pass through it quickly. But the kidney is the parking lot where the toxins get stuck and do their damage. If you want to know what poisons are in a city's water supply, don't look at the river flowing through it; look at the sediment at the bottom of the filter.

5. Why This Matters

This paper changes how we think about cancer prevention.

• Old Way: We wait for people to get sick, then try to figure out what caused it.
• New Way: We can look at the "receipts" in healthy cells to see what poisons are currently circulating in our population.

The Big Takeaway:
Your kidneys are like a highly sensitive canary in a coal mine. They are recording a history of everything you've been exposed to in your life. By reading the DNA of these healthy cells, scientists can now identify hidden environmental dangers—like unknown plant toxins or regional pollutants—before they turn into cancer.

It's like realizing that the "noise" in your DNA isn't just static; it's a historical diary of your life, written by the environment, waiting to be read.

Technical Summary

1. Problem Statement

• The Gap in Cancer Etiology: While environmental and lifestyle factors are known to cause ~80% of cancers in high-income countries, the specific causes for a significant portion of these cases remain unidentified. Conventional epidemiology has struggled to detect these causes in recent decades.
• Limitations of Cancer Genomics: Previous studies analyzing mutational signatures in cancer genomes are confounded by mutations acquired during neoplastic transformation (endogenous processes activated by cancer). It is difficult to distinguish whether a mutational signature is caused by an external exposure or is a byproduct of the cancer's evolution.
• The Need for Normal Tissue Analysis: To definitively identify exogenous mutagens, researchers must analyze normal cells where the mutational burden reflects lifetime exposure without the noise of cancer-specific genomic instability. However, detecting somatic mutations in normal tissues has historically been technically challenging due to low mutation frequencies and sequencing errors.

2. Methodology

The study employed a high-sensitivity genomic approach to map mutational landscapes in normal human kidney tissues across a global population.

• Cohort and Sampling:

  • Samples: 319 normal kidney samples and 272 blood samples from 10 countries (Brazil, Canada, Czechia, Japan, Lithuania, Romania, Russia, Serbia, Thailand, UK).
  • Context: Most donors had clear cell renal cell carcinoma (ccRCC); 16 UK donors were non-cancer controls.
  • Tissue Types:
    • Bulk Cortex: Total DNA from kidney cortex.
    • Laser-Capture Microdissection (LCM): Specific nephron structures (glomeruli, proximal tubules, medulla, distal tubules) were isolated from 84 individuals to analyze cell-type specificity.
    • Blood: Peripheral blood mononuclear cells for comparison.

• Sequencing Technology (NanoSeq):

  • Utilized single-molecule duplex sequencing (NanoSeq), an error-corrected method that sequences both strands of DNA.
  • This allows for the reliable detection of somatic mutations at very low frequencies (down to ~1 in 10^6 bases), distinguishing true somatic variants from sequencing artifacts.
  • Coverage: Achieved a median of 3 Gb effective duplex coverage per library, covering ~30% of the genome (restricted by restriction enzyme sites).

• Bioinformatics and Analysis:

  • Variant Calling: Custom pipelines (NanoSeq analysis) with strict filters to exclude germline variants (using matched blood/bulk normal) and artifacts.
  • Signature Extraction: Used two algorithms (Hierarchical Dirichlet Process and SigProfilerExtractor) to perform de novo extraction of mutational signatures.
  • Decomposition: Extracted signatures were decomposed against COSMIC v3.4 reference signatures. Novel signatures were identified if they could not be reconstructed by known references.
  • Statistical Modeling: Linear mixed-effects models were used to estimate mutation rates per year, accounting for age, sex, country, and tissue structure.

3. Key Contributions

1. First High-Resolution Map of Normal Kidney Mutations: Provided the most comprehensive catalog of somatic mutations in normal human kidney cells to date, utilizing duplex sequencing to overcome previous sensitivity limits.
2. Cell-Type Specificity in Mutagenesis: Demonstrated that proximal tubule cells accumulate significantly higher mutation burdens than other nephron structures (glomeruli, distal tubules, medulla) and most other normal tissues, despite having low mitotic division rates.
3. Validation of Exogenous Origins: Established a framework to distinguish exogenous mutagens from endogenous processes by confirming the presence of specific signatures in normal tissues and observing geographic/lifestyle variations.
4. Discovery of Novel/Re-evaluated Signatures: Identified and characterized signatures of unknown origin (SBS40b, SBS40c, SBS12) and confirmed the systemic nature of known carcinogens (Aristolochic acid, tobacco smoke).

4. Key Results

A. Mutational Signatures and Geographic Variation

• Aristolochic Acid (SBS22a, SBS22b, SBS22c, ID23):
  • Found predominantly in samples from Romania and Serbia.
  • Confirmed as an exogenous, systemically circulating mutagen (ingested, absorbed, circulated).
  • Shows strong transcriptional strand bias, typical of bulky DNA adducts.
• SBS12 (Japan-Specific):
  • Found almost exclusively in Japanese donors (both normal kidney and ccRCC).
  • Presence in normal cells confirms an exogenous origin (likely a regional environmental agent) rather than a cancer-specific process.
• SBS40b and SBS40c:
  • SBS40b: Shows geographic variation (high in Czechia, low in Japan) and correlates with ccRCC incidence rates, age, and male sex. Suggests a systemically circulating exogenous mutagen or a kidney-specific response to environmental factors.
  • SBS40c: Present in normal kidney with transcriptional strand bias, suggesting an exogenous origin, though without clear geographic variation in this cohort.
• Tobacco Smoke (SBSB):
  • A signature similar to SBS4 (tobacco) was found in normal kidney and correlates with smoking history. It is enriched in proximal tubules, indicating systemic circulation of tobacco chemicals.

B. Cell-Type Specific Mutation Burdens

• Proximal Tubules as "Sentinels":
  • Proximal tubules accumulated ~60 SBS and ~7.8 indels per genome per year.
  • This rate is comparable to or higher than rapidly dividing tissues (e.g., colorectal epithelium) despite the low division rate of tubule cells.
  • Mechanism: Likely due to the physiological function of proximal tubules: active reabsorption and secretion of organic compounds from the blood, leading to high intracellular concentrations of circulating mutagens.
• Comparison with Other Structures:
  • Glomeruli, medulla, and distal tubules showed significantly lower burdens of exogenous signatures (e.g., SBS22, SBS12, SBS40b).
  • Endogenous signatures (SBS1, SBS5, SBS40a) showed more uniform distribution or lower rates in proximal tubules compared to exogenous ones.

C. Normal vs. Cancer Genomes

• Mutation Burden: ccRCC genomes had modestly higher mutation burdens (~30% more SBS) than their matched normal proximal tubules.
• Signature Stability: The burden of exogenous signatures (Aristolochic acid, SBS12, SBS40b) was similar or slightly higher in normal proximal tubules than in the resulting cancer. This indicates that the mutagenic exposure occurs primarily in the normal tissue before transformation, and the cancer does not significantly amplify these specific signatures.
• Cancer-Specific Signatures: Signatures like SBS18 (ROS), SBS21, SBS44 (MMR defects), and SBS_H (XPC loss) were found in cancer but not in normal tissue, confirming they arise during neoplastic evolution.

D. Blood vs. Kidney

• Peripheral blood samples did not show the geographic variation or the specific exogenous signatures (SBS22, SBS12, SBS40b) found in the kidney.
• This highlights that blood is not a suitable reporter for these specific systemic mutagens, whereas kidney proximal tubules are highly sensitive "sensors."

5. Significance and Implications

• New Paradigm for Mutational Epidemiology: The study proposes using normal tissue genomes (specifically kidney proximal tubules) as a "biological archive" to survey lifetime exposures to systemically circulating mutagens at a population level.
• Identification of Unknown Carcinogens: The findings strongly implicate SBS12 (Japan) and SBS40b/40c as signatures of currently unknown exogenous mutagens. This provides a target for future epidemiological and experimental research to identify the causative agents.
• Mechanism of Tissue Specificity: The study elucidates why certain organs are more susceptible to specific cancers: the physiological function of the cell type (e.g., proximal tubule reabsorption) concentrates circulating mutagens, leading to higher mutation burdens and cancer risk.
• Refining Cancer Prevention: By identifying that a large portion of mutation burden in normal cells comes from exogenous sources (some unknown), the study underscores the potential for further cancer prevention strategies once these agents are identified.

In summary, this paper demonstrates that normal kidney proximal tubule cells are uniquely sensitive reporters of systemic environmental mutagens, revealing a complex landscape of known and unknown carcinogenic exposures that drive cancer risk, distinct from the mutational processes that occur during tumor evolution.